To access this element change to forms mode OFF
Grant Award View - GA294937
Improving outcomes for high-risk child and adolescent cancer: from...
GA ID:
GA294937
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
10-Oct-2022
Publish Date:
12-Apr-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2027
Value (AUD):
$5,085,000.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Synergy Grants
Grant Activity:
Improving outcomes for high-risk child and adolescent cancer: from discovery to individualised treatment within a consumer partnership
Purpose:
Cancer is the commonest disease causing death in children. New anticancer drugs are developed against one adult cancer gene target. Anticancer drugs work best in combination to overcome resistance. Our network of scientists and doctors have developed a diagnostic platform to better match the drug to the gene target for high risk child cancer. We will develop effective child cancer-specific combination therapy, accurate diagnostics for resistance and integrate consumers in the research pathway.
GO ID:
GO Title:
Synergy Grants 2022
Internal Reference ID:
2022/GNT2018642
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA